Kangshun Zhu

12PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersGene and molecular therapyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 03, 2025
Sorafenib Combined with Tislelizumab and Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: A Phase II Study.

Licong Liang, Jingwen Zhou, Jingjun Huang

|Jan 31, 2024
Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study.

Mingyue Cai, Wensou Huang, Wei Liang

|Oct 17, 2023
Intratumoral Lactate Depletion Based on Injectable Nanoparticles-Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence.

Ye Chen, Jiaxin Bei, Meijuan Chen

|Mar 01, 2023
Effectiveness of lenvatinib plus immune checkpoint inhibitors in primary advanced hepatocellular carcinoma beyond oligometastasis.

Xiao-Hui Wang, Chang-Jun Liu, Hao-Quan Wen

|Feb 22, 2023
T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.

Xiaobin Wang, Qiaoyun Zhang, Jingwen Zhou

|Jan 13, 2023
Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases.

Mingyu Liu, Lulu Xie, Yuying Zhang

Pageof 2

Frequent Collaborators

3 joint publications

Jingjun Huang

3 joint publications

Wensou Huang

2 joint publications

Mingyue Cai

1 joint publications

Xiao-Hui Wang